4-Bromo-6-(difluoromethyl)pyrimidine, 95.0%, 500mg

2,5-Diaminoterephthalonitrile, 97.0%, 500mg

5-BROMO-3-(1-METHYL-1,2,3,6-TETRAHYDROPYRIDIN-4-YL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 250mg

(2E,4Z)-2-Cyano-5-dimethylamino-3-(4-methoxy-phenyl)-penta-2,4-dienoic acid methyl ester, 95.0%, 5g

Di-potassium oxalate monohydrate, min. 98.5%, pa, ACS, 500 g, plastic packaging.

10-Methyl-10H-phenothiazine-3,7-dicarbaldehyde, 98%, 100mg

1-[2-Fluoro-4-(methylsulfonyl)phenyl]piperidine-4-carboxamide, 1g

(R)-(+)-1-(4-Methoxyphenyl)ethyl isocyanate, 98.0%, 1g

2-Phenyl-1H-pyrrole, 95.0%, 250mg

Methyl-(4-methyl-benzyl)-piperidin-3-yl-amine hydrochloride, 95.0%, 100mg

2,5-Dimethyl-thiophene-3-carboxylic acid, 95.0%, 25g

2-Hydroxymethyl-1H-benzoimidazole-5-carboxylic acid, 95.0%, 25g

exo BCN-O-PNB, 250mg